celecoxib has been researched along with valganciclovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baryawno, N; Darabi, A; FuskevÅg, OM; Johnsen, JI; Khan, Z; Kogner, P; Nordenskjöld, M; Odeberg, J; Rahbar, A; Segerström, L; Siesjö, P; Söderberg-Nauclér, C; Sveinbjörnsson, B; Taher, C; Wolmer-Solberg, N | 1 |
1 review(s) available for celecoxib and valganciclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for celecoxib and valganciclovir
| Article | Year |
|---|---|
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.
Topics: Adult; Animals; Antiviral Agents; Brain Neoplasms; Celecoxib; Cell Line, Tumor; Child; Child, Preschool; Cyclooxygenase 2 Inhibitors; Cytomegalovirus; Dinoprostone; Female; Ganciclovir; Humans; Infant; Male; Medulloblastoma; Mice; Mice, Nude; Middle Aged; Pyrazoles; Sulfonamides; Valganciclovir; Virus Replication; Xenograft Model Antitumor Assays; Young Adult | 2011 |